Care.com Inc CRCM, an online platform to help people find and manage family care, is reportedly undertaking a strategic review and could sell itself in the $14 to $16 per share range, according to BTIG.
The Analyst
BTIG analyst Marvin Fong maintains a Buy rating on Care's stock with a $13 price target.
The Thesis
Care.com appears to be "ripe for a possible sale" of itself given multiple vacant positions in senior management along with frustrated shareholders and pressure from activist investor Engine Capital, Fong wrote in a note.
On the other hand, the company does have a leading platform within an attractive market with a short list of potential buyers, including IAC/InterActiveCorp IAC, Internet Brands, or a private equity group.
Fong said a potential buyer would appreciate Care's more enhanced background checks and management's strategy to fight back against recent negative press. The company also boasts a "sound" balance sheet and positive free cash flow.
At this point a sale is "more likely than not" to take place and a price tag of $14 to $16 implies a multiple of 22 to 26 times 2020 estimated Adjusted EBITDA.
Price Action
Shares of Care.com were trading higher by 8.4% Monday at $12.13.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.